Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1993 Sep;67(9):5640–5646. doi: 10.1128/jvi.67.9.5640-5646.1993

Structural and functional characterization of rev-like transcripts of equine infectious anemia virus.

R Rosin-Arbesfeld 1, M Rivlin 1, S Noiman 1, P Mashiah 1, A Yaniv 1, T Miki 1, S R Tronick 1, A Gazit 1
PMCID: PMC237968  PMID: 8394464

Abstract

Three cDNA clones representing structurally distinct transcripts were isolated from a cDNA library prepared from cells infected with equine infectious anemia virus (EIAV) by using a probe representing the S3 open reading frame, which is thought to encode Rev. One species, designated p2/2, contained four exons and was identical to a previously described polycistronic mRNA that encodes Tat. This transcript was predicted to also direct the synthesis of a truncated form of the transmembrane protein and a putative Rev protein whose N-terminal 29 amino acids, derived from env, are linked to S3 sequences. The second cDNA, p176, also consisted of four exons which were generated by two of three of the same splicing events that occur with p2/2 but not with the Tat mRNA. The alternative splice site giving rise to the second exon of p176 results in a bicistronic message that would encode the same transmembrane and Rev proteins as p2/2. The first exon of the third transcript, p20, was identical to those of p2/2 and p176 but was spliced directly to S3. This monocistronic message could encode a second form of Rev that lacks env sequences, provided that Rev synthesis would initiate at a non-AUG codon. The coding capacity of each cDNA was assessed in a eukaryotic system using S3 antisera. Two putative Rev proteins with apparent molecular masses of 18 and 16 kDa were expressed by p2/2 and p176, while p20 expressed only a 16-kDa species. Analysis of EIAV-infected cells with S3 antisera revealed the presence of an 18-kDa protein. Surprisingly, the same protein was detected in purified virions. By using a reporter construct, the chloramphenicol acetyltransferase gene linked to EIAV env sequences, we were able to demonstrate greatly enhanced chloramphenicol acetyltransferase activity in cells cotransfected with this construct and any of the three cDNAs.

Full text

PDF
5640

Images in this article

5643Image
on p.5643
5644Image
on p.5644

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acland P., Dixon M., Peters G., Dickson C. Subcellular fate of the int-2 oncoprotein is determined by choice of initiation codon. Nature. 1990 Feb 15;343(6259):662–665. doi: 10.1038/343662a0. [DOI] [PubMed] [Google Scholar]
  2. Arrigo S. J., Weitsman S., Zack J. A., Chen I. S. Characterization and expression of novel singly spliced RNA species of human immunodeficiency virus type 1. J Virol. 1990 Sep;64(9):4585–4588. doi: 10.1128/jvi.64.9.4585-4588.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beisel C. E., Edwards J. F., Dunn L. L., Rice N. R. Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in an acutely infected horse reveals a novel protein, Ttm, derived from the carboxy terminus of the EIAV transmembrane protein. J Virol. 1993 Feb;67(2):832–842. doi: 10.1128/jvi.67.2.832-842.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berger J., Aepinus C., Dobrovnik M., Fleckenstein B., Hauber J., Böhnlein E. Mutational analysis of functional domains in the HIV-1 Rev trans-regulatory protein. Virology. 1991 Aug;183(2):630–635. doi: 10.1016/0042-6822(91)90992-k. [DOI] [PubMed] [Google Scholar]
  5. Bugler B., Amalric F., Prats H. Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol Cell Biol. 1991 Jan;11(1):573–577. doi: 10.1128/mcb.11.1.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chakrabarti L., Guyader M., Alizon M., Daniel M. D., Desrosiers R. C., Tiollais P., Sonigo P. Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature. 1987 Aug 6;328(6130):543–547. doi: 10.1038/328543a0. [DOI] [PubMed] [Google Scholar]
  7. Colombini S., Arya S. K., Reitz M. S., Jagodzinski L., Beaver B., Wong-Staal F. Structure of simian immunodeficiency virus regulatory genes. Proc Natl Acad Sci U S A. 1989 Jul;86(13):4813–4817. doi: 10.1073/pnas.86.13.4813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cullen B. R. Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol Rev. 1992 Sep;56(3):375–394. doi: 10.1128/mr.56.3.375-394.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Curran T., Gordon M. B., Rubino K. L., Sambucetti L. C. Isolation and characterization of the c-fos(rat) cDNA and analysis of post-translational modification in vitro. Oncogene. 1987;2(1):79–84. [PubMed] [Google Scholar]
  10. Davis J. L., Clements J. E. Characterization of a cDNA clone encoding the visna virus transactivating protein. Proc Natl Acad Sci U S A. 1989 Jan;86(2):414–418. doi: 10.1073/pnas.86.2.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dorn P., DaSilva L., Martarano L., Derse D. Equine infectious anemia virus tat: insights into the structure, function, and evolution of lentivirus trans-activator proteins. J Virol. 1990 Apr;64(4):1616–1624. doi: 10.1128/jvi.64.4.1616-1624.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Garvey K. J., Oberste M. S., Elser J. E., Braun M. J., Gonda M. A. Nucleotide sequence and genome organization of biologically active proviruses of the bovine immunodeficiency-like virus. Virology. 1990 Apr;175(2):391–409. doi: 10.1016/0042-6822(90)90424-p. [DOI] [PubMed] [Google Scholar]
  13. Gourdou I., Mazarin V., Quérat G., Sauze N., Vigne R. The open reading frame S of visna virus genome is a trans-activating gene. Virology. 1989 Jul;171(1):170–178. doi: 10.1016/0042-6822(89)90524-2. [DOI] [PubMed] [Google Scholar]
  14. Greene W. C. The molecular biology of human immunodeficiency virus type 1 infection. N Engl J Med. 1991 Jan 31;324(5):308–317. doi: 10.1056/NEJM199101313240506. [DOI] [PubMed] [Google Scholar]
  15. Guatelli J. C., Gingeras T. R., Richman D. D. Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells. J Virol. 1990 Sep;64(9):4093–4098. doi: 10.1128/jvi.64.9.4093-4098.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Guyader M., Emerman M., Sonigo P., Clavel F., Montagnier L., Alizon M. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature. 1987 Apr 16;326(6114):662–669. doi: 10.1038/326662a0. [DOI] [PubMed] [Google Scholar]
  17. Hope T. J., McDonald D., Huang X. J., Low J., Parslow T. G. Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus. J Virol. 1990 Nov;64(11):5360–5366. doi: 10.1128/jvi.64.11.5360-5366.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Horikami S. M., Moyer S. A. Synthesis of leader RNA and editing of the P mRNA during transcription by purified measles virus. J Virol. 1991 Oct;65(10):5342–5347. doi: 10.1128/jvi.65.10.5342-5347.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kalinski H., Yaniv A., Mashiah P., Miki T., Tronick S. R., Gazit A. rev-like transcripts of caprine arthritis encephalitis virus. Virology. 1991 Aug;183(2):786–792. doi: 10.1016/0042-6822(91)91012-6. [DOI] [PubMed] [Google Scholar]
  20. Kawakami T., Sherman L., Dahlberg J., Gazit A., Yaniv A., Tronick S. R., Aaronson S. A. Nucleotide sequence analysis of equine infectious anemia virus proviral DNA. Virology. 1987 Jun;158(2):300–312. doi: 10.1016/0042-6822(87)90202-9. [DOI] [PubMed] [Google Scholar]
  21. Kjems J., Frankel A. D., Sharp P. A. Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev. Cell. 1991 Oct 4;67(1):169–178. doi: 10.1016/0092-8674(91)90580-r. [DOI] [PubMed] [Google Scholar]
  22. Kozak M. Context effects and inefficient initiation at non-AUG codons in eucaryotic cell-free translation systems. Mol Cell Biol. 1989 Nov;9(11):5073–5080. doi: 10.1128/mcb.9.11.5073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kozak M. Effects of intercistronic length on the efficiency of reinitiation by eucaryotic ribosomes. Mol Cell Biol. 1987 Oct;7(10):3438–3445. doi: 10.1128/mcb.7.10.3438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Malim M. H., Böhnlein S., Hauber J., Cullen B. R. Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function. Cell. 1989 Jul 14;58(1):205–214. doi: 10.1016/0092-8674(89)90416-9. [DOI] [PubMed] [Google Scholar]
  25. Malim M. H., Hauber J., Le S. Y., Maizel J. V., Cullen B. R. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature. 1989 Mar 16;338(6212):254–257. doi: 10.1038/338254a0. [DOI] [PubMed] [Google Scholar]
  26. Malim M. H., McCarn D. F., Tiley L. S., Cullen B. R. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J Virol. 1991 Aug;65(8):4248–4254. doi: 10.1128/jvi.65.8.4248-4254.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Malim M. H., Tiley L. S., McCarn D. F., Rusche J. R., Hauber J., Cullen B. R. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell. 1990 Feb 23;60(4):675–683. doi: 10.1016/0092-8674(90)90670-a. [DOI] [PubMed] [Google Scholar]
  28. Mazarin V., Gourdou I., Querat G., Sauze N., Audoly G., Vitu C., Russo P., Rousselot C., Filippi P., Vigne R. Subcellular localization of rev-gene product in visna virus-infected cells. Virology. 1990 Sep;178(1):305–310. doi: 10.1016/0042-6822(90)90410-s. [DOI] [PubMed] [Google Scholar]
  29. Mazarin V., Gourdou I., Quérat G., Sauze N., Vigne R. Genetic structure and function of an early transcript of visna virus. J Virol. 1988 Dec;62(12):4813–4818. doi: 10.1128/jvi.62.12.4813-4818.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Miki T., Matsui T., Heidaran M. A., Aaronson S. A. An efficient directional cloning system to construct cDNA libraries containing full-length inserts at high frequency. Gene. 1989 Nov 15;83(1):137–146. doi: 10.1016/0378-1119(89)90411-3. [DOI] [PubMed] [Google Scholar]
  31. Miller M. A., Garry R. F., Jaynes J. M., Montelaro R. C. A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides. AIDS Res Hum Retroviruses. 1991 Jun;7(6):511–519. doi: 10.1089/aid.1991.7.511. [DOI] [PubMed] [Google Scholar]
  32. Noiman S., Gazit A., Tori O., Sherman L., Miki T., Tronick S. R., Yaniv A. Identification of sequences encoding the equine infectious anemia virus tat gene. Virology. 1990 May;176(1):280–288. doi: 10.1016/0042-6822(90)90254-o. [DOI] [PubMed] [Google Scholar]
  33. Noiman S., Yaniv A., Sherman L., Tronick S. R., Gazit A. Pattern of transcription of the genome of equine infectious anemia virus. J Virol. 1990 Apr;64(4):1839–1843. doi: 10.1128/jvi.64.4.1839-1843.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Noiman S., Yaniv A., Tsach T., Miki T., Tronick S. R., Gazit A. The Tat protein of equine infectious anemia virus is encoded by at least three types of transcripts. Virology. 1991 Oct;184(2):521–530. doi: 10.1016/0042-6822(91)90422-8. [DOI] [PubMed] [Google Scholar]
  35. Oberste M. S., Greenwood J. D., Gonda M. A. Analysis of the transcription pattern and mapping of the putative rev and env splice junctions of bovine immunodeficiency-like virus. J Virol. 1991 Jul;65(7):3932–3937. doi: 10.1128/jvi.65.7.3932-3937.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Olsen H. S., Nelbock P., Cochrane A. W., Rosen C. A. Secondary structure is the major determinant for interaction of HIV rev protein with RNA. Science. 1990 Feb 16;247(4944):845–848. doi: 10.1126/science.2406903. [DOI] [PubMed] [Google Scholar]
  37. Querat G., Audoly G., Sonigo P., Vigne R. Nucleotide sequence analysis of SA-OMVV, a visna-related ovine lentivirus: phylogenetic history of lentiviruses. Virology. 1990 Apr;175(2):434–447. doi: 10.1016/0042-6822(90)90428-t. [DOI] [PubMed] [Google Scholar]
  38. Rice N. R., Henderson L. E., Sowder R. C., Copeland T. D., Oroszlan S., Edwards J. F. Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus. J Virol. 1990 Aug;64(8):3770–3778. doi: 10.1128/jvi.64.8.3770-3778.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Robert-Guroff M., Popovic M., Gartner S., Markham P., Gallo R. C., Reitz M. S. Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J Virol. 1990 Jul;64(7):3391–3398. doi: 10.1128/jvi.64.7.3391-3398.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Rushlow K., Olsen K., Stiegler G., Payne S. L., Montelaro R. C., Issel C. J. Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus. Virology. 1986 Dec;155(2):309–321. doi: 10.1016/0042-6822(86)90195-9. [DOI] [PubMed] [Google Scholar]
  41. Saltarelli M., Querat G., Konings D. A., Vigne R., Clements J. E. Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. Virology. 1990 Nov;179(1):347–364. doi: 10.1016/0042-6822(90)90303-9. [DOI] [PubMed] [Google Scholar]
  42. Sargan D. R., Bennet I. D. A transcriptional map of visna virus: definition of the second intron structure suggests a rev-like gene product. J Gen Virol. 1989 Aug;70(Pt 8):1995–2006. doi: 10.1099/0022-1317-70-8-1995. [DOI] [PubMed] [Google Scholar]
  43. Sherman L., Gazit A., Yaniv A., Kawakami T., Dahlberg J. E., Tronick S. R. Localization of sequences responsible for trans-activation of the equine infectious anemia virus long terminal repeat. J Virol. 1988 Jan;62(1):120–126. doi: 10.1128/jvi.62.1.120-126.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Spence A. M., Sheppard P. C., Davie J. R., Matuo Y., Nishi N., McKeehan W. L., Dodd J. G., Matusik R. J. Regulation of a bifunctional mRNA results in synthesis of secreted and nuclear probasin. Proc Natl Acad Sci U S A. 1989 Oct;86(20):7843–7847. doi: 10.1073/pnas.86.20.7843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Stephens R. M., Derse D., Rice N. R. Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins. J Virol. 1990 Aug;64(8):3716–3725. doi: 10.1128/jvi.64.8.3716-3725.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Tiley L. S., Brown P. H., Le S. Y., Maizel J. V., Clements J. E., Cullen B. R. Visna virus encodes a post-transcriptional regulator of viral structural gene expression. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7497–7501. doi: 10.1073/pnas.87.19.7497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Unger R. E., Stout M. W., Luciw P. A. Simian immunodeficiency virus (SIVmac) exhibits complex splicing for tat, rev, and env mRNA. Virology. 1991 May;182(1):177–185. doi: 10.1016/0042-6822(91)90661-t. [DOI] [PubMed] [Google Scholar]
  48. Venkatesh L. K., Chinnadurai G. Mutants in a conserved region near the carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit a dominant negative phenotype. Virology. 1990 Sep;178(1):327–330. doi: 10.1016/0042-6822(90)90414-m. [DOI] [PubMed] [Google Scholar]
  49. Venkatesh L. K., Mohammed S., Chinnadurai G. Functional domains of the HIV-1 rev gene required for trans-regulation and subcellular localization. Virology. 1990 May;176(1):39–47. doi: 10.1016/0042-6822(90)90228-j. [DOI] [PubMed] [Google Scholar]
  50. Viglianti G. A., Sharma P. L., Mullins J. I. Simian immunodeficiency virus displays complex patterns of RNA splicing. J Virol. 1990 Sep;64(9):4207–4216. doi: 10.1128/jvi.64.9.4207-4216.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Zapp M. L., Green M. R. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature. 1989 Dec 7;342(6250):714–716. doi: 10.1038/342714a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES